Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Health And Human Services was posted on June 27, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

A Solicitation of the Advanced Research Project Agency for Health (ARPA-H) for Small Business Innovative Research (SBIR) Contract Proposals- SOLICITATION AND ALL AMENDMENTS (1-4)

Closed
75N91023R00041Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541715
New
Federal
U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) Organic Industrial Base (OIB) Modernization Commercial Solutions Opening (CSO)
Solicitation # W911PT26SC001
The U.S. Army Contracting Command – Watervliet Arsenal (ACC-WVA) has issued solicitation W911PT26SC001, a Commercial Solutions Opening (CSO) authorized under the National Defense Authorization Act for Fiscal Year 2026 and DFARS Subpart 212.70. This competitive solicitation is open until September 30, 2027, and is designed to acquire innovative commercial products, technologies, and services to modernize the Army's Organic Industrial Base. The scope focuses on integrating manufacturing resources, linking legacy analogue systems with digital systems, and expanding modeling and simulation to enhance the delivery of materiel solutions. The CSO targets both traditional and non-traditional business entities, including small businesses and foreign-owned firms, provided they maintain an active System for Award Management (SAM) profile and a Unique Entity ID. The acquisition process follows a multi-phased approach consisting of a written solution brief, an optional presentation or pitch, and a final Request for Commercial Solution Proposal (CSP). Evaluation is based on responsiveness, technical merit, uniqueness, and price reasonableness. Successful responses may result in fixed-price contracts awarded under FAR Part 12 Commercial Item Procedures. Current Areas of Interest (AoIs) include advanced cannon technology, electrical infrastructure improvements at Building 120, chromium facility conversion, automated manufacturing for minor components, automated cooling tower treatments, advanced CNC vertical turning lathes, and advanced tooling for radial forging. Performance is primarily located at Watervliet Arsenal and Benet Laboratories, with a general period of performance not to exceed 12 months unless otherwise specified.
W6QK Acc Wva

POSTED

about 16 hours ago

DEADLINE

in 11 months
NAICS: 541715
New
Grant
Coordinating Center for National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
Solicitation # RFA-DC-28-002
Solicitation RFA-DC-28-002 is a Notice of Funding Opportunity from the National Institutes of Health, specifically the National Institute on Deafness and Other Communication Disorders, to establish a Coordinating Center for the NIDCD National Human Ear Resource Network. This collaborative network provides human inner and middle ear tissues to researchers for basic and clinical studies aimed at advancing the treatment of auditory and vestibular disorders. The Coordinating Center is responsible for maintaining network cohesiveness through the planning of workshops, symposia, and regular meetings, providing updates to laboratories, and managing communication with the public and scientific community regarding tissue donation. The maximum project period is five years, with a budget limit of 200,000 dollars in direct costs per year. Applicants, including for-profit organizations and small businesses, must maintain active registrations in SAM, eRA Commons, and Grants.gov. Proposals are evaluated based on the significance of the proposed center and the qualifications of the investigators, with additional reviews for human subject protections, inclusion policies, and the use of vertebrate animals. Key requirements include a structured Data Management and Sharing Plan and adherence to cybersecurity guidelines, including a 48-hour incident reporting window. The application process is entirely electronic and requires several standard PHS and SF424 forms, with a response deadline of March 5, 2027.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

in 5 months
NAICS: 541715
New
Grant
National Resource Network for the Study of Human Auditory and Vestibular Disorders (U24 Clinical Trial Not Allowed)
Solicitation # RFA-DC-28-001
Solicitation RFA-DC-28-001 is a Notice of Funding Opportunity issued by the National Institutes of Health under the Department of Health and Human Services to support the NIDCD National Human Ear Resource Network. The objective is to maintain a collaborative network of laboratories that serve as a national technological resource, providing human inner and middle ear tissues to researchers for basic and clinical studies to advance the treatment of auditory and vestibular disorders. The scope of work includes processing human temporal bones from the National Hearing and Balance Organ Donor Program, uploading images and medical data to EarBase, sharing gene-expression data via the gEAR repository, and providing technical instruction to increase the number of skilled researchers in the field. The NIDCD intends to commit 3.6 million dollars in FY 2028 to fund up to six awards, with a maximum project period of five years. Individual awards are limited to 450,000 dollars in direct costs per year, with an additional 150,000 dollars available for specific subawards. Applications are due on March 05, 2027, and November 01, 2027, with staggered start dates ranging from July 2027 to July 2028. Evaluation is based on the experience of the investigators, the adequacy of the institutional environment, and the protection of human subjects. Applicants must maintain active SAM registration and a Unique Entity Identifier, and they must provide a Data Management and Sharing Plan and a Material Transfer Agreement. Compliance with the Cybersecurity Act of 2015 is required, including the development of an incident response plan and notification of cybersecurity incidents within 48 hours of discovery.
National Institutes Of Health

POSTED

1 day ago

DEADLINE

in about 1 year

General Info

Contract Value

$4,218,974

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Rockville, MD, 20850, USA

Set-Aside

SBA

Award Issued Date

Documents

20

75N91023R00041 Amendment 03

PDF, High priority: read this firstamendment
High

75N91023R00041 Amendment 2

PDF, High priority: read this firstamendment
High

75N91023R00041 Appendix A - Phase I Technical Proposal

DOCX, High priority: read this firstsow
High

75N91023R00041 Appendix B - Phase I Business Proposal (Amend 4)

DOCX, High priority: read this firstamendment
High

Appendix A - Phase I Technical Proposal Template

DOCX, High priority: read this firstspecifications
High

Appendix B - Phase II Business Proposal Template

DOCX, High priority: read this firstspecifications
High

Appendix C - Phase II Technical Proposal Template

DOCX, High priority: read this firstspecifications
High

Appendix D - Phase II Business Proposal

DOCX, High priority: read this first7 pages · specifications
High

Appendix E - Proposal Fundamentals

PDF, High priority: read this firstspecifications
High

Appendix E - Proposal Fundamentals (Amendment 4 to 75N91023R00041)

DOCX, High priority: read this first7 pages · amendment
High

Appendix F - Contract Requirements

PDF, High priority: read this firstspecifications
High

ARPA-H SBIR Program Solicitation

PDF, High priority: read this firstrfp
High

Solicitation 75N91023R00041 Amendment 1

PDF, High priority: read this firstamendment
High

Solicitation 75N91023R00041 Amendment 4

PDF, High priority: read this firstamendment
High

Solicitation 75N91023R00041 Appendix B - Phase I Business Proposal (Amend 3)

DOCX, High priority: read this first8 pages · amendment
High

Solicitation 75N91023R00041 - Appendix C: Phase II Technical Proposal (Amend 3)

DOCX, High priority: read this first7 pages · rfp
High

Solicitation 75N91023R00041 Appendix D - Phase II Business Proposal Amendment 4

DOCX, High priority: read this first9 pages · amendment
High

APPENDIX A.1 — HUMAN SUBJECTS AND CLINICAL TRIALS INFORMATION FORM

PDF, Low priorityother
Low

Appendix G - Definitions

PDF, Low priorityspecifications
Low

PHS Human Subjects and Clinical Trials Information Form

PDF, Low priorityother
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

5 updates
PhaseClosed
Posted

Presolicitation

Type Changed

Presolicitation → Solicitation

Notice updated

The notice title changed. The notice description changed.

Notice updated

The notice title changed.

Notice updated

The notice title changed. The notice description changed.

Notice updated

The notice title changed. The notice description changed.

Notice updated

The notice title changed. The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA

Full Description

Show more
AMENDMENT #4 TO THE SOLICIATION: to 1) Provide the .pdf files for Human Subject Attachments A.1 and A.2 and; 2) Revised Appendix E and the Phase I and II business proposal applications to include FAR Provision 52.204-24 and FAR Clause 52.204-26. See attachments: 75N91023R00041 AMENDMENT 4, APPENDIX A.1 - HUMAN SUBJECTS AND CLINICAL TRIALS INFORMATION FORM, APPENDIX B - Phase I Business Proposal, APPENDIX D - Phase II Business Proposal, APPENDIX E - PROPOSAL FUNDAMENTALS, and HumanSubjectStudy_3_0-V3.0 Form H 5-23. Offerors are required to acknowledge each Solicitation Amendment by including each Standard Form 30, attached, (SF-30) signed by your organization's signature authority and submitted with your proposal. Proposal Due Date: July 3, 2023, 5:00PM EDT (Unchanged) AMENDMENT #3 TO THE SOLICIATION: The purpose of this amendment is to respond to additional questions received regarding solicitation 75N91023R00041. See attachments entitled, "SBIR SOLICITATION 75N91023R00041 QA AMENDMENT 3.pdf, APPENDIX A - Phase I Technical Proposal - Amend 3, APPENDIX B - Phase I Business Proposal - Amend 3 and APPENDIX C - Phase II Technical Proposal - Amend 3" for full amendment. Offerors are required to acknowledge each Solicitation Amendment by including each Standard Form 30, attached, (SF-30) signed by your organization's signature authority and submitted with your proposal. Proposal Due Date: July 3, 2023, 5:00PM EDT (Unchanged) AMENDMENT #2 TO THE SOLICIATION: The purpose of this amendment is to respond to questions received regarding solicitation 75N91023R00041. See attachment entitled, "75N91023R00041 AMENDMENT 2.pdf" for full amendment. Offerors are required to acknowledge each Solicitation Amendment by including each Standard Form 30, attached, (SF-30) signed by your organization's signature authority and submitted with your proposal. Proposal Due Date: July 3, 2023, 5:00PM EDT (Unchanged) AMENDMENT #1 TO THE SOLICITATION: The purpose of this amendment is change the due date for Solicitation Questions from June 12, 2023, 5:00PM EDT to June 14, 2023, 5:00PM EDT. Offerors are required to acknowledge each Solicitation Amendment by including each Standard Form 30, attached, (SF-30) signed by your organization's signature authority and submitted with your proposal. Proposal Due Date: July 3, 2023, 5:00PM EDT (Unchanged). Please see attached for Solicitation 75N91023R00041 and all associated attachments. Attachments include: ARPA-H SBIR SOLITICATION APPENDIX A - Phase I Technical Proposal APPENDIX B - Phase I Business Proposal APPENDIX C - Phase II Technical Proposal APPENDIX D - Phase II Business Proposal APPENDIX E - PROPOSAL FUNDAMENTALS APPENDIX F - CONTRACT REQUIREMENTS APPENDIX G - DEFINITIONS

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 541715
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance the research and development of medical interventions for infectious diseases. This initiative focuses on three primary research areas: the development of needle-free vaccine candidates through early-phase clinical trials; the creation of safe and effective therapeutic candidates for serious infectious diseases, including those resistant to current antimicrobial therapy; and the innovation of in vitro diagnostic technology platforms capable of rapid, automated detection of a broad panel of priority viral pathogens. The program emphasizes alignment with NIH priorities regarding biosafety, biosecurity, and the use of non-animal testing methods. Proposals must be submitted electronically via the NIAID eCPS website by December 8, 2026, at 3:00 PM Eastern Time. Technical proposals are limited to 75 pages and will be evaluated by a peer review group based on technical merit, with the technical plan and personnel qualifications being of paramount consideration. Awards are not based on a common Statement of Work; instead, offerors must propose their own technical plans, milestones, and cost structures using a base and option period format. The resulting contracts will require an accounting system compliant with generally accepted accounting principles and will involve rigorous government inspection and acceptance based on the successful completion of critical milestones.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

12 days ago

DEADLINE

in about 2 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS